DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Gustine JN, Meid K, Dubeau T. et al.
Ibrutinib discontinuation in Waldenström macroglobulinemia: etiologies, outcomes, and IgM rebound.
Am J Hematol 2018;
93 (04) 511-517
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.